Project Details
Description
Insecticides are substances that help eliminate insects and mites that cause human diseases such as malaria. While there are benefits to their use, they can also pose a serious threat to both wildlife and humans, for example through toxic residues in food and water. This issue has encouraged research into the creation of low-risk insecticides. One area research has explored is the role of the enzyme cytochrome P450 (CYP) in the sensitivity to insecticides. The EU-funded CypTox project will exploit the CYP metabolic/detoxification pathway of target and non-target organisms in order to develop insecticides that are highly selective and safe. The project’s work will also lead to state-of-the-art biotechnology platforms.
Acronym | CypTox |
---|---|
Status | Active |
Effective start/end date | 1/01/21 → 31/12/24 |
Collaborative partners
- Universitat Autònoma de Barcelona (UAB)
- Idryma Technologias Kai Erevnas (Forth) (Coordinator) (lead)
- Agricultural University of Athens (Project partner)
- Endura Spa (Project partner)
- Magma Antiprosopeysi kai emporia Georgikon Proionton Kai Efodion (EISROES) (Project partner)
- University of Valencia (UV) (Project partner)
- Cypex Limited (Project partner)
- Ghent University (Universiteit Gent) (Project partner)
- University of Exeter (Project partner)
- Enzyquest Private Company (Project partner)
- Universitat Autònoma de Barcelona (UAB) (Project partner)
- Bionos Biotech SL (Project partner)
- Devgen nv (Project partner)
- Syngenta Crop Protection AG (Project partner)
- The International Centre of Insect Physiology and Ecology LBG (ICIPE) (Project partner)
- Syngenta Limited (Project partner)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.